Page last updated: 2024-08-23

nigericin and gemcitabine

nigericin has been researched along with gemcitabine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, Y; Yao, D; Zheng, Q; Zhou, T	1

Other Studies

1 other study(ies) available for nigericin and gemcitabine

Article	Year
NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway. Bioscience reports, 2020, 07-31, Volume: 40, Issue:7 Topics: Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Inflammasomes; Interleukin-1beta; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Thiazolidines; Thiones; Triple Negative Breast Neoplasms; Up-Regulation; Wnt Signaling Pathway	2020

Article

Year

NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway.

Bioscience reports, 2020, 07-31, Volume: 40, Issue:7

Topics: Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Inflammasomes; Interleukin-1beta; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Thiazolidines; Thiones; Triple Negative Breast Neoplasms; Up-Regulation; Wnt Signaling Pathway

2020